Patent reform bill reported to House

Share this article:
The House Judiciary Committee voted before the summer congressional recess to approve and send to the House a bill observers said would overhaul the US patent system by weeding out bad patents and restraining excessive litigation over patents. The measure continues to be opposed by drug and biotech firms.

The bill reportedly would give parties more leeway to question patent validity and would limit damage awards in infringement cases.

“Past attempts at achieving comprehensive patent reform have met with stiff resistance,” said bill chief sponsor Rep. Howard Berman (D-CA).  

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.